Delivery Order SPE2DB22D3016-SPE2DB25FABF7
Award Date
10/22/24
Potential Completion Date
11/13/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GAMUNEX-C 20 gram/200 ml vial medical products to the Defense Logistics Agency (DLA), a defense agency. The fixed-price contract has a ceiling value of $51,257.64 and an ultimate completion date of June 12, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This contract is not set aside and represents open competition....
This federal contract award is for the delivery of GAMUNEX-C 40 gram/400 ml vial pharmaceutical products to the Defense Logistics Agency (DLA). The $24,045.40 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 30, 2024, with a completion date of November 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The federal contract award is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML medical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $27,926.40 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 24, 2025. There is no set-aside designation for this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,125.92 firm-fixed-price delivery order is for the supply of 4566734911 - GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of GAMUNEX-C 5 GRAM/50 ML VIAL 50ML. The contract is a Firm Fixed Price Delivery Order valued at $3,551.16 with an ultimate completion date of August 30, 2024. Amerisourcebergen, the prime contractor, has been awarded this contract to supply this critical medical product to support various government agencies and healthcare...
This federal contract award is for the delivery of GAMUNEX-C 20 gram/200 ml vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,377.17 and an ultimate completion date of March 28, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $24,876.40 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024, with a performance period ending on December 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,462.92 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400 ML medical products. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $49,752.80 for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,076.11, is for the delivery of GAMUNEX-C 20 gram/200 mL vials. The contract is a Firm Fixed Price delivery order with a completion date of May 30, 2023. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...